Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.41 | N/A |
PEG Ratio (TTM) | -0.80 | N/A |
P/S Ratio (TTM) | 1.72 | N/A |
P/B Ratio (TTM) | -18.40 | N/A |
P/FCF Ratio (TTM) | -1.77 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -50.35% | N/A |
ROE (TTM) | -9,769.41% | N/A |
Net Profit Margin (TTM) | -119.24% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.57% | -1,809.20% | N/A |
Revenue | -26.60% | -6.12% | N/A |
Net Income | -6.93% | 124.22% | N/A |
Cash Flow | -0.83% | 1,792.79% | N/A |
Health (11%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.59 | N/A |
Quick Ratio (TTM) | 0.59 | N/A |
D/E Ratio (TTM) | -6.39 | N/A |
Interest Coverage (TTM) | -36.45 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |